{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:24:13Z","timestamp":1793921053194,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154375","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:47:08Z","timestamp":1788706028000},"page":"154375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Development of hyaluronic acid-triamcinolone acetonide transparent formulation for efficient endotoxin-induced uveitis therapy"],"prefix":"10.1016","volume":"382","author":[{"given":"Yuan-Shao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihenew Simegniew","family":"Birhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Shan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154375_bb0005","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ophtha.2014.07.007","article-title":"Long-term clinical outcome and causes of vision loss in patients with uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","article-title":"Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"123","author":"Dick","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.iae.0000250601.15893.5f","article-title":"Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion","volume":"Suppl (8)","author":"Nguyen","year":"2006","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154375_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ophtha.2010.03.029","article-title":"A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States","volume":"118","author":"Nguyen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","author":"Rosenbaum","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154375_bb0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: the corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs"},{"issue":"Suppl 1(Suppl. 1)","key":"10.1016\/j.ijbiomac.2026.154375_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000318021","article-title":"New developments in corticosteroid therapy for uveitis","volume":"224","author":"Taylor","year":"2010","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154375_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40942-021-00358-w","article-title":"Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study","volume":"8","author":"Miller","year":"2022","journal-title":"Int. J. Retina Vitreous"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154375_bb0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11095-010-0292-6","article-title":"The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal","volume":"28","author":"Choy","year":"2011","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154375_bb0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154375_bb0055","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ajo.2005.01.022","article-title":"Cataract progression after intravitreal triamcinolone injection","volume":"139","author":"Cekic","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0060","first-page":"52","article-title":"Posterior subcapsular cataracts as a complication of adrenocortical steroid therapy","volume":"86","author":"Toogood","year":"1962","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajo.2023.06.021","article-title":"Incidence of and risk factors for cataract in anterior uveitis","volume":"254","author":"Papaliodis","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/IAE.0b013e3181f049a8","article-title":"Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema","volume":"31","author":"Chew","year":"2011","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.eye.6702304","article-title":"Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years","volume":"21","author":"Islam","year":"2007","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154375_bb0080","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1167\/iovs.06-0889","article-title":"Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells","volume":"48","author":"Gupta","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154375_bb0085","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1167\/iovs.02-1091","article-title":"Expression of the functional glucocorticoid receptor in mouse and human lens epithelial cells","volume":"44","author":"Gupta","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.exer.2008.04.003","article-title":"Search for a functional glucocorticoid receptor in the mammalian lens","volume":"88","author":"Gupta","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154375_bb0095","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1039\/C1MB05045A","article-title":"Glucocorticoid receptors take part in the apoptotic process of human lens epithelial cells, but the glucocorticoid receptor antagonist RU486 does not rescue the cells fully","volume":"7","author":"Wang","year":"2011","journal-title":"Mol. BioSyst."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154375_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract","volume":"23","author":"James","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2013.03.006","article-title":"Dexamethasone influences FGF-induced responses in lens epithelial explants and promotes the posterior capsule coverage that is a feature of glucocorticoid-induced cataract","volume":"111","author":"Wang","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118474","article-title":"Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract","volume":"568","author":"Srinivasarao","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"35","key":"10.1016\/j.ijbiomac.2026.154375_bb0115","doi-asserted-by":"crossref","first-page":"16485","DOI":"10.1039\/C8NR00058A","article-title":"A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats","volume":"10","author":"Mahaling","year":"2018","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154375_bb0120","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.nano.2016.05.017","article-title":"Physicochemical properties of core\u2013shell type nanoparticles govern their spatiotemporal biodistribution in the eye","volume":"12","author":"Mahaling","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144265","article-title":"Size-controlled immunomodulatory and vaccine adjuvant potentials of self-assembled hyaluronic acid nanoparticles: activation and recruitment of immune cells","volume":"314","author":"Chu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154375_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-1681.1984.tb00235.x","article-title":"Elimination of hyaluronic acid from the blood stream in the human","volume":"11","author":"Fraser","year":"1984","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154375_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","article-title":"Hyaluronan: its nature, distribution, functions and turnover","volume":"242","author":"Fraser","year":"1997","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154375_bb0140","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/03639040802713460","article-title":"Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model","volume":"35","author":"Di Colo","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","article-title":"Hyaluronic acid coated poly-\u025b-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea","volume":"87","author":"Yenice","year":"2008","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154375_bb0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.144.4.789","article-title":"LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan","volume":"144","author":"Banerji","year":"1999","journal-title":"J. Cell Biol."},{"issue":"48","key":"10.1016\/j.ijbiomac.2026.154375_bb0155","doi-asserted-by":"crossref","first-page":"37733","DOI":"10.1074\/jbc.M003030200","article-title":"Identification of the hyaluronan receptor for endocytosis (HARE)","volume":"275","author":"Zhou","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154375_bb0160","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acs.bioconjchem.9b00475","article-title":"Hyaluronic acid-antibody fragment bioconjugates for extended ocular pharmacokinetics","volume":"30","author":"Famili","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154375_bb0165","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.biomaterials.2011.01.003","article-title":"Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy","volume":"32","author":"Oh","year":"2011","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154375_bb0170","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1016\/j.biomaterials.2013.04.035","article-title":"Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection","volume":"34","author":"Gan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.152930","article-title":"DIC\/Oxyma as efficient amide coupling agent for synthesis of amphiphilic hyaluronic acid conjugates in co-solvent systems","volume":"371","author":"Wijerathna","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124047","article-title":"Development of triamcinolone acetonide-hyaluronic acid conjugates with selective targeting and less osteoporosis effect for rheumatoid arthritis treatments","volume":"237","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.154375_bb0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jchromb.2011.01.012","article-title":"Quantification of triamcinolone acetonide in ocular tissues after intravitreal injection to rabbit using liquid chromatography-tandem mass spectrometry","volume":"879","author":"Zhang","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000267163","article-title":"Retino-choroidal changes in endotoxin-induced uveitis in the rat","volume":"24","author":"Ruiz-Moreno","year":"1992","journal-title":"Ophthalmic Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154375_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101569","article-title":"Hyaluronic acid-glycine-cholesterol conjugate-based nanoemulsion as a potent vaccine adjuvant for T cell-mediated immunity","volume":"13","author":"Lin","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154375_bb0200","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.eye.6702063","article-title":"Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis","volume":"20","author":"Das-Bhaumik","year":"2006","journal-title":"Eye (Lond.)"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154375_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/app.52327","article-title":"Biotin-decorated redox-responsive micelles from diselenide-linked star-shaped copolymers for the targeted delivery and controlled release of doxorubicin in cancer cells","volume":"139","author":"Birhan","year":"2022","journal-title":"J. Appl. Polym. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2011.06.031","article-title":"Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response","volume":"156","author":"Mizrahy","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120255","article-title":"Combinatorial synthesis of a hyaluronan based polysaccharide library for enhanced CD44 binding","volume":"300","author":"Liu","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.154375_bb0220","doi-asserted-by":"crossref","first-page":"30170","DOI":"10.1074\/jbc.M110.137562","article-title":"Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan","volume":"285","author":"Wolny","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154375_bb0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12974-024-03175-8","article-title":"CD44 signaling in M\u00fcller cells impacts photoreceptor function and survival in healthy and diseased retinas","volume":"21","author":"Ayten","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.exer.2006.03.005","article-title":"Captopril suppresses inflammation in endotoxin-induced uveitis in rats","volume":"83","author":"Ilieva","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2017.02.011","article-title":"Glucocorticoid-induced leucine zipper overexpression inhibits lipopolysaccharide-induced retinal inflammation in rats","volume":"165","author":"Gu","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.aopr.2024.11.003","article-title":"Nano-based drug delivery systems for the treatment of non-infectious uveitis","volume":"5","author":"Wu","year":"2025","journal-title":"Adv. Ophthalmol. Pract. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020683","article-title":"Development of triamcinolone acetonide nanocrystals for ocular administration","volume":"15","author":"Formica","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0250","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbm.a.30917","article-title":"In vitro evaluation of in situ gels as short term vitreous substitutes","volume":"79","author":"Suri","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0255","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitkanen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2008.08.002","article-title":"The lens capsule","volume":"88","author":"Danysh","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154375_bb0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.matbio.2009.12.004","article-title":"Characterizing molecular diffusion in the lens capsule","volume":"29","author":"Danysh","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijbiomac.2026.154375_bb0270","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/IJN.S179118","article-title":"High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit","volume":"14","author":"Yu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154375_bb0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/138945011794182746","article-title":"Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration","volume":"12","author":"M Becerra","year":"2011","journal-title":"Curr. Drug Targets"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026043217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026043217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:25:04Z","timestamp":1793917504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026043217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":55,"alternative-id":["S0141813026043217"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154375","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of hyaluronic acid-triamcinolone acetonide transparent formulation for efficient endotoxin-induced uveitis therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154375"}}